These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22492528)

  • 1. Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition.
    Düfer M; Hörth K; Wagner R; Schittenhelm B; Prowald S; Wagner TF; Oberwinkler J; Lukowski R; Gonzalez FJ; Krippeit-Drews P; Drews G
    Diabetes; 2012 Jun; 61(6):1479-89. PubMed ID: 22492528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of FXR in β-cells of lean and obese mice.
    Schittenhelm B; Wagner R; Kähny V; Peter A; Krippeit-Drews P; Düfer M; Drews G
    Endocrinology; 2015 Apr; 156(4):1263-71. PubMed ID: 25599407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Atorvastatin and the Farnesoid X Receptor Impair Insulinotropic Effects of Bile Acids and Modulate Diabetogenic Risk.
    Hoffmeister T; Kaiser J; Lüdtke S; Drews G; Düfer M
    Mol Pharmacol; 2020 Mar; 97(3):202-211. PubMed ID: 31911428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose stimulates Ca2+ influx and insulin secretion in 2-week-old beta-cells lacking ATP-sensitive K+ channels.
    Szollosi A; Nenquin M; Aguilar-Bryan L; Bryan J; Henquin JC
    J Biol Chem; 2007 Jan; 282(3):1747-56. PubMed ID: 17138557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression.
    Kong X; Tu Y; Li B; Zhang L; Feng L; Wang L; Zhang L; Zhou H; Hua X; Ma X
    Mol Metab; 2019 Nov; 29():1-11. PubMed ID: 31668381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells.
    Miura A; Yamagata K; Kakei M; Hatakeyama H; Takahashi N; Fukui K; Nammo T; Yoneda K; Inoue Y; Sladek FM; Magnuson MA; Kasai H; Miyagawa J; Gonzalez FJ; Shimomura I
    J Biol Chem; 2006 Feb; 281(8):5246-57. PubMed ID: 16377800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
    Remedi MS; Nichols CG
    PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between membrane potential and cytosolic Ca2+ concentration in beta cells from Sur1-/- mice.
    Haspel D; Krippeit-Drews P; Aguilar-Bryan L; Bryan J; Drews G; Düfer M
    Diabetologia; 2005 May; 48(5):913-21. PubMed ID: 15830184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
    Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in beta cell Ca²+ signalling, glucose metabolism and insulin secretion in a murine model of K(ATP) channel-induced neonatal diabetes mellitus.
    Benninger RK; Remedi MS; Head WS; Ustione A; Piston DW; Nichols CG
    Diabetologia; 2011 May; 54(5):1087-97. PubMed ID: 21271337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function.
    Ropero AB; Soriano S; Tudurí E; Marroquí L; Téllez N; Gassner B; Juan-Picó P; Montanya E; Quesada I; Kuhn M; Nadal A
    Endocrinology; 2010 Aug; 151(8):3665-74. PubMed ID: 20555029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
    Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
    J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
    Ritzel RA; Hansen JB; Veldhuis JD; Butler PC
    J Clin Endocrinol Metab; 2004 Feb; 89(2):795-805. PubMed ID: 14764798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells.
    Nenquin M; Szollosi A; Aguilar-Bryan L; Bryan J; Henquin JC
    J Biol Chem; 2004 Jul; 279(31):32316-24. PubMed ID: 15175349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity.
    Popescu IR; Helleboid-Chapman A; Lucas A; Vandewalle B; Dumont J; Bouchaert E; Derudas B; Kerr-Conte J; Caron S; Pattou F; Staels B
    FEBS Lett; 2010 Jul; 584(13):2845-51. PubMed ID: 20447400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Derlin-1 protein in proteostasis regulation of ATP-sensitive potassium channels.
    Wang F; Olson EM; Shyng SL
    J Biol Chem; 2012 Mar; 287(13):10482-10493. PubMed ID: 22311976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinism in mice with heterozygous loss of K(ATP) channels.
    Remedi MS; Rocheleau JV; Tong A; Patton BL; McDaniel ML; Piston DW; Koster JC; Nichols CG
    Diabetologia; 2006 Oct; 49(10):2368-78. PubMed ID: 16924481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.
    Muñoz A; Hu M; Hussain K; Bryan J; Aguilar-Bryan L; Rajan AS
    Endocrinology; 2005 Dec; 146(12):5514-21. PubMed ID: 16123162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor.
    Soriano S; Ropero AB; Alonso-Magdalena P; Ripoll C; Quesada I; Gassner B; Kuhn M; Gustafsson JA; Nadal A
    Mol Endocrinol; 2009 Dec; 23(12):1973-82. PubMed ID: 19855088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.